Mayo Clinic Talks

This episode is shared from Mayo Clinic Q&A and was recorded in May, 2020.

Guest: Tanios S. Bekaii-Saab, M.D. (@GIcancerDoc)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

Because cancer treatments can weaken the immune system, cancer patients are at increased risk of complications from COVID-19. Despite these concerns, cancer patients often still need treatment, including going to the clinic or to the hospital, and many have questions about whether cancer should be treated differently during the COVID-19 pandemic.

On the Mayo Clinic Q&A podcast, Dr. Tanios Bekaii-Saab, a Mayo Clinic oncologist, explains how cancer patients can safely continue their cancer treatment during the pandemic.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in April, 2020.

Guest:  Tina Ardon, M.D. (@TinaArdon)

Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)

As the COVID-19 pandemic continues, the World Health Organization (WHO) says more than 117 million children in 37 countries may be missing out on the lifesaving measles vaccine. The WHO had issued some guidelines to help countries sustain immunization activities during the COVID-19 pandemic. 

On the Mayo Clinic Q&A podcast, Dr. Tina Ardon, a Mayo Clinic family medicine physician, discusses the importance of childhood vaccinations. Dr. Ardon also discusses masking guidelines for children during the COVID-19 pandemic.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded on April 16, 2020.

Guest: M. Nadir Bhuiyan, M.D. (@DrNadirMD); Ravindra Ganesh, M.B.B.S., M.D.; Ryan T. Hurt, M.D., Ph.D.

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

While not all patients with COVID-19 will require hospitalization, many are seeking care and medical advice from their primary providers.  With public health measures limiting travel and clinical visits, the question facing many healthcare organizations is: how do they safely provide care and monitor patients with COVID-19?  

In this two-part episode on telemedicine, Dr. Amit Ghosh speaks with Drs. Nadir Bhuiyan, Ravindra Ganesh, and Ryan Hurt about the Mayo Clinic COVID-19 Frontline Care Team and their efforts to establish a telemedicine practice for patients with COVID-19.  Listen as they share key steps to successfully providing remote care, address concerns of COVID-19 positive patients, and mobilize a multifunctional team of healthcare professionals.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded on April 16, 2020.

Guest: M. Nadir Bhuiyan, M.D. (@DrNadirMD); Ravindra Ganesh, M.B.B.S., M.D.; Ryan T. Hurt, M.D., Ph.D.

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

While not all patients with COVID-19 will require hospitalization, many are seeking care and medical advice from their primary providers.  With public health measures limiting travel and clinical visits, the question facing many healthcare organizations is: how do they safely provide care and monitor patients with COVID-19?  

In this two-part episode on telemedicine, Dr. Amit Ghosh speaks with Drs. Nadir Bhuiyan, Ravindra Ganesh, and Ryan Hurt about the Mayo Clinic COVID-19 Frontline Care Team and their efforts to establish a telemedicine practice for patients with COVID-19.  Listen as they share key steps to successfully providing remote care, address concerns of COVID-19 positive patients, and mobilize a multifunctional team of healthcare professionals.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode is shared from Mayo Clinic Q&A and was recorded on April 29, 2020

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest:  Gregory A. Poland, M.D.  (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

Each week, the Mayo Clinic Q&A podcast shares the latest information on the COVID-19 pandemic. On today's episode, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, answers listeners' coronavirus questions. Topics include: pets and COVID-19, ultraviolet light and viruses, and herd immunity.

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode was recorded in April, 2020.

Guest: Daniel A. Diedrich, M.D.

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

COVID-19 was first identified late last year with a cluster of pneumonia cases caused by a new coronavirus. The COVID-19 disease process heavily affects the respiratory system, and patients often need oxygen support. The respiratory therapist plays a critical role in managing oxygen levels, placing breathing tubes, and managing the mechanical ventilator, when necessary.

On the Mayo Clinic Q&A podcast, Dr. Daniel Diedrich, a Mayo Clinic anesthesiologist and critical care physician, discusses the role of the respiratory therapist from the time a patient presents with COVID-19 all the way through that patient's discharge.

• AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded on April 22, 2020.

Guest:  Rahul Kashyap, M.B.B.S. (@Dr_SRKashyap)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

Real time data collection is essential for developing evidence based guidelines when facing emerging pathogens. Dr. Rahul Kashyap discusses VIRUS, a multinational multicenter rapid data collection process and how you can participate. 

• Discovery VIRUS COVID-19 Registry (@covid19registry) 
  https://www.sccm.org/Research/Research/Discovery-Research-Network/VIRUS-COVID-19-Registry  
• NIH - Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry (COVID-19)  https://clinicaltrials.gov/ct2/show/NCT04323787  
• AskMayoExpert COVID-19 Resources:  https://askmayoexpert.mayoclinic.org/navigator/COVID-19  

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in April, 2020.

Guest:  Amanda Kubista Owen

Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)

People around the world have been under stay-at-home orders to prevent the spread of coronavirus. While this situation isn't ideal, it can be dangerous for some. For people in abusive situations, home may not be a safe environment.

On the Mayo Clinic Q&A podcast, Amanda Kubista Owen, a Mayo Clinic social worker, discusses services available to help support people affected by domestic violence and why having a safety plan is important.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode is shared from Mayo Clinic Q&A and was recorded April 22, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest:  Gregory A. Poland, M.D.  (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, covers the latest news on the COVID-19 pandemic. Dr. Poland discusses current outbreak numbers, why there may be a second wave of infections, and research on a vaccine.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded on April 20, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest: Regan N. Theiler, M.D., Ph.D.  (@TheilerRegan)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

Does pregnancy itself make a woman more susceptible to COVID-19? What advice should we be giving to pregnant women in the third trimester? How is remote monitoring being utilized? Dr. Regan Theiler discusses how they’re advising and caring for pregnant patients, what’s being reported as potential complications for pregnant patients who’ve been infected with SARS-CoV-2, and what isolation precautions should be applied during and after delivery.

Deeper Dive:

• Mayo Clinic COVID-19 Resources for Providers  https://www.mayoclinic.org/medical-professionals/provider-relations/covid-19-resources-for-providers
• Society for Maternal - Fetal Medicine: Clinical Guidance on COVID-19  https://www.smfm.org/covidclinical
• Society for Obstetric Anesthesia and Perinatology - COVID-19 Toolkit  https://soap.org/education/provider-education/expert-summaries/interim-considerations-for-obstetric-anesthesia-care-related-to-covid19/

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode is shared from Mayo Clinic Q&A and was recorded April, 2020.

Guest:  Andrew Badley, M.D. (@BadleyAndrew)

Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)

As the SARS-CoV-2 virus spread worldwide, a race began to develop testing protocols and ramp up research. Mayo Clinic's COVID-19 research task force is studying the virus, predicting hot spots, and working towards effective treatments and a vaccine.

On the Mayo Clinic Q&A podcast, Dr. Andrew Badley, chair of Mayo Clinic’s COVID-19 research task force, gives an update on COVID-19 research activities at Mayo Clinic. 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode is shared from Mayo Clinic Q&A and was recorded on April 20, 2020.

Guest:  Gregory Poland, M.D. (@drgregpoland)

Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)

As the COVID-19 pandemic continues, efforts are underway to find a new normal and begin to re-open the country and the economy. While people are eager for strict social distancing rules to end, public health measures, including testing and tracing for the virus, will be important tools needed to control the spread of the virus and prevent an uptick in new infections.

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, discusses the steps needed to reopen businesses, schools and other activities as the fight to control COVID-19 continues.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded April 2020.

Guest:  Elitza S. Theel, Ph.D.

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

A new serology test from Mayo Clinic Laboratories is being used to identify the presence of immune response to SARS-CoV-2, the virus that causes COVID-19. The serology test is intended only to detect antibodies to the virus. It does not diagnose recent or active infection. Mayo Clinic Laboratories also offers a molecular test to diagnose very recent or active infection. Both tests are important tools in the pandemic response. 

On the Mayo Clinic Q&A podcast, Dr. Elitza Theel, director of Mayo Clinic’s Infectious Diseases Serology Laboratory, explains why serology testing is initially focused on identifying people in areas where potential immunity is key, including front-line health care workers.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded on April 15, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest:  Alexander S. Niven, M.D. (@niven_alex)
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

When a patient presents with dyspnea how can we reliably predict who will progress to respiratory failure? How can phenotypes of disease progression be utilized for optimizing selection of treatment modalities? Dr. Alex Niven discusses Fleischner Society recommendations for imaging as a COVID-19 screening tool, cytokine storm, ventilator-associated lung injury, post-ICU care syndrome, and humanity in critical care.

Deeper Dive:

• Mayo Clinic COVID-19 Resources for Providers 
  https://www.mayoclinic.org/medical-professionals/provider-relations/covid-19-resources-for-providers
• Fleischner Society Guidelines
  Rubin G, Haramati L, Kanne J, et al. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the Fleischner Society. Radiology. 2020 April 07; p.201365. https://doi.org/10.1148/radiol.2020201365
• The Berlin Definition
  The ARDS Definition Task Force. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Guest: Sanjeev Nanda, M.D. (@SNandaMD)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

In 2016, diagnostic criterion was established, finally removing fibromyalgia as a “diagnosis of exclusion.” Still, given the number of manifestations, it’s a challenging disorder to evaluate and treat. Sanjeev Nanda, M.D., shares his expert insights on this complicated condition.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A and was recorded in April 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest:  Nipunie S. Rajapakse, M.D., M.P.H. (@nrajapakseMD)

Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)

How is SARS-CoV-2 affecting pregnant women? Is breastfeeding safe? How can a pregnant woman protect herself from the disease? On the Mayo Clinic Q&A podcast, Dr. Nipunie Rajapakse, a pediatric infectious diseases specialist, will discuss COVID-19 and pregnancy.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded on April 8, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest:  Christopher S. Russi, D.O. (@csrussi)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

How can telehealth be used to care for COVID-19 patients? How can we leverage telehealth to bring resources to rural facilities? Collaboration through telehealth can provide care where it’s convenient for patients, help offload cognitive burden from colleagues, and mitigate exposure and PPE challenges during this pandemic. Dr. Christopher Russi walks through how the process works and how it’s being leveraged at Mayo Clinic under typical circumstances and how it’s being utilized to triage and inform care for suspected and confirmed COVID-19 patients.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode is shared from Mayo Clinic Q&A and was recorded on Monday, April 6th, 2020.

Guest:  Gregory A. Poland, M.D.  (@drgregpoland)

Host: Halena M. Gazelka, M.D. (@hmgazelkamd)

To prevent the spread of COVID-19, the Centers for Disease Control and Prevention (CDC) now recommends that Americans wear cloth masks in public settings where other social distancing measures are difficult to maintain. The CDC considers cloth masks an additional, voluntary public health measure.

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, a Mayo Clinic COVID-19 expert, explains the difference between medical masking and public masking, and discusses the proper way to put a mask on and off to prevent the spread of disease.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Deeper Dive:

• Use of Cloth Face Coverings to Help Slow the Spread of COVID-19

Guest: Janet Vittone, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Janet Vittone, M.D., outlines the difference between different advanced directive documents and the importance of discussing these with all of your patients. She shares tips on when and how to broach the topic with patients, especially those in early adulthood. Drs. Vittone and Chutka also discuss ensuring that the right people are aware of your wishes, should you become incapacitated.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Deeper Dive:

• Living wills and advance directives for medical decisions, by Mayo Clinic: https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/living-wills/art-20046303
• Patient education video: https://www.mayoclinic.org/healthy-lifestyle/consumer-health/multimedia/advance-directives-awarness/vid-20114292

This episode is shared from Mayo Clinic Q&A and was recorded on April 3, 2020. 

To claim credit visit: https://ce.mayo.edu/covid19podcast 

Guest:  Gregory A. Poland, M.D.  (@drgregpoland) 

Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 

Dr. Greg Poland returns to share an update on the COVID-19 pandemic in this episode shared from Mayo Clinic Q&A to discuss the latest in antibody testing, coronavirus immunity, and whether or not it’s safe to wear contact lenses. 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode was recorded on April 3, 2020

Claim credit here: https://ce.mayo.edu/covid19podcast

Guest:  Michael J. Ackerman, M.D., Ph.D. (@MJAckermanMDPhD)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)

The administration of hydroxychloroquine and azithromycin, along with other very common medications could result in drug-induced sudden cardiac death caused by drug-induced QT prolongation, in some patients. In order to avoid the wrong medication, for the wrong patient, at the wrong time, Dr. Michael Ackerman shares how to assess your patient’s risk, how to find and measure their QTc value, and neutralize the threat.

Deeper Dive:

• Link to Journal Pre-Proof:
  https://mayoclinicproceedings.org/pb/assets/raw/Health%20Advance/journals/jmcp/jmcp_covid19.pdf
• Link to COVID-19 QTc Calculator and other resources:
  https://www.covidqtc.com/#WRchTxt7-12ve

Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19 [published online ahead of print March 25, 2020]. Mayo Clin Proc. https://doi.org/10.1016/j.mayocp.2020.03.024.

• FDA Emergency Use Authorization (EUA) of hydroxychloroquine sulfate: https://www.fda.gov/media/136538/download
• Mayo Clinic Connected Care - Genetic Heart Rhythm Diseases https://connect.mayoclinic.org/page/genetic-heart-rhythm-disorders/tab/covid-19/#

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode is shared from Mayo Clinic Q&A.

Guest: Elie Berbari, MD (@DODElie)

Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)

The ongoing fight against the COVID-19 pandemic has heavily burdened front-line health care providers. "Our nation and our medical community is facing an unprecedented challenge," says Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic. 

On the Mayo Clinic Q&A podcast, Dr. Berbari discusses how Mayo Clinic is minimizing exposure to staff, while providing safe and compassionate care to patients. 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

This episode is shared from Mayo Clinic Q&A and was recorded on March 31, 2020.

Guest:  Gregory Poland, M.D.

Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)

A novel coronavirus is a new strain that has not been seen before in humans. SARS-Co-V2 is a novel virus, causing the disease COVID-19. Because COVID-19 is a new disease, much is still being learned about how it spreads and the severity of illness it causes. 

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, infectious disease expert and head of Mayo Clinic’s Vaccine Research Group, explains the science behind how the virus makes people sick, and what the virus does to the body. Dr. Poland will also discuss the latest information on clinical trials and vaccine research to fight the disease outbreak.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Guest: Alicia M. Hinze, M.D., M.H.S. (@alicia_hinze)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Alicia M. Hinze, M.D., M.H.S., provides an overview of osteoarthritis and other rheumatologic conditions. Dr. Hinze shares her approach to distinguishing between osteoarthritis and inflammatory arthritis, along with risk factors for developing osteoarthritis over time, including genetics, professions, prior injuries, and age. She shares recommendations for conservative therapies and at what point surgical intervention should be considered.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode was recorded on Monday, March 30, 2020.

Claim credit here: https://ce.mayo.edu/covid19podcast

Guest:  Matthew P. Van Cuyk, Pharm.D., R.Ph. 

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

Should we be using ibuprofen to treat patients with COVID-19? Does this fall into the modifiable risk category? Dr. Matthew Van Cuyk breaks down recent events and literature around ibuprofen use in patients with COVID-19. 

Deeper Dive:

1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. March 2020. https://doi.org/10.1016/S2213-2600(20)30116-8
2. HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
3. ASHP Coronavirus Resource Center: https://www.ashp.org/Pharmacy-Practice/Resource-Centers/Coronavirus
4. Assessment of Evidence for COVID-19-Related Treatments: Updated 3/27/2020

For the most up to date COVID-19 information:

• CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
• WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019